VentriPoint Diagnostics applies for CE Mark for VMS+ device

Medtech group VentriPoint Diagnostics Ltd (CVE:VPT) says it has applied for a CE mark for its ground-breaking VMS+ heart monitoring device.

The machine permits for analysis of all four chambers of the heart using data from a conventional 2D (two dimensional) eco-cardiogram.

"This is a major milestone for the company as it shows the VMS+ device, including the 4-chamber analysis software package, was ready for addition to the company's product registration in Europe," stated Dr George Adams, chief executive of Ventripoint.

The CE mark, permitting goods to be sold in Europe, is recognized worldwide and will permit the company to register these products in many additional countries and regions.

The company will begin this procedure as soon as the VMS+ has been added to its CE Mark.

The group also said it had been successful in a re-certification audit for its quality management system that is precise to medical devices.